AVGO

Outcome

—

Return

—

Status

—

Subscribe to read

Outcome

—

Return

—

Status

—

Subscribe to read

Outcome

✓

Return

+0.39%

Status

scored

Maintain Hold on AVGO with a tactical 10-15% trim at $360-365 to address the bleeding-Hold failure mode, while setting a hard stop at $325 and requiring confirmed close above $372 (50 SMA) on volume >25M before adding. The 12-month structural target remains $450 contingent on Q4 FY26 validating the $19.39 forward EPS consensus, with a pre-committed 20-25% trim into the early December earnings print.

Outcome

✗

Return

-4.35%

Status

scored

All three analysts converge on Hold for AVGO at ~$380, with the aggressive case's exceptional fundamentals (19.4x forward P/E, 0.37 PEG, 75.5% gross margins, 44% ROE, $30B+ FCF) offset by unsustainable 85% YoY growth and multiple risk in a 1.48-beta stock with 10Y at 2002 highs. The recommended framework is to hold current position, await pullback entry to $355-365, maintain hard stop at $343, and reassess after Q4 FY26 binary print in early December—with upgrade trigger at confirmed close >$385 with volume >25M and MACD crossing above zero.

Outcome

✓

Return

+0.19%

Status

scored

Maintain Hold on AVGO at ~$380 with hard stop at $360, as the one-day Bollinger upper breakout is too early to confirm a new uptrend given negative MACD line and binary Q4 FY26 catalyst 8-10 weeks away. Upgrade to Buy requires confirmed close >$380-385 on volume >25M with MACD crossing above zero and RSI>55; downgrade to Underweight triggers on close <$360 on heavy volume.

Outcome

✗

Return

+3.67%

Status

scored

Maintain HOLD on AVGO at ~$362 with a simplified, catalyst-conditional architecture: do not add at current levels, stage a 20-25% trim into any confirmed push toward the $370-380 resistance zone (50 SMA $372.30, 200 SMA $366.38, Bollinger upper $371.30), and hard stop at $340. Position sizing is capped at 60-70% of normal AVGO weight due to 1.48 beta and binary Q4 FY26 earnings risk, with explicit calendar pre-commitment to the early December print to avoid the 09-30 bleeding-Hold failure mode.

Outcome

✓

Return

+2.08%

Status

scored

Maintain Hold on AVGO at ~$355 as the cleanest synthesis of analyst consensus, preserving the developing basing pattern optionality while pre-committing 20-25% trims at Q4 FY26 earnings (early December) and 20-25% at December FOMC to force action at known catalysts and prevent the bleeding-Hold failure mode.

Outcome

✗

Return

+3.35%

Status

scored

Trim AVGO 25-30% at $340-345, maintaining Underweight with a hard stop at $310 on residuals; the setup matches the worst-case 09-30 Hold scenario (forward EPS requiring +223% YoY, confirmed downtrend, hostile macro), making tiered Hold architecture the wrong choice. Re-engage on 200 SMA reclaim at $366 with volume >18M and RSI>50, or on a flush to $300-320 with stabilization signals; Q4 FY26 earnings and December FOMC serve as pre-committed calendar catalysts.

Outcome

✗

Return

-2.15%

Status

scored

Maintain HOLD with a tiered architecture that staggers entry across three levels: Tier 1 (25%) requires confirmed close above $366 with above-average volume and RSI>50, Tier 2 (50%) activates on sustained hold above $374 for 5+ sessions, and Tier 3 (25%) triggers on $400 reclaim with momentum; an optional 10-15% starter position is available at $338 on bullish reversal candle with RSI<30. Pre-committed 25% trims into Q4 FY26 earnings (early December) and 25% into December FOMC, with hard stop at $338 close on expanding volume and alpha circuit breaker of -0.75% vs SPY over 15 days. The rating remains HOLD due to binding constraints on the bull case—the forward EPS arithmetic ($2.68 × 4 = $10.72, not $19.38 consensus) requires +223% YoY Q4 growth against a tough comp, while macro headwinds (30Y yield at 2002 highs, beta 1.46) and confirmed downtrend technicals cap upside without structural confirmation.

Outcome

–

Return

-1.10%

Status

scored

Trim AVGO to Underweight, cutting 25-30% of existing exposure at ~$355. The rating reflects an 18.3x forward P/E that prices in extraordinary Q3 FY26 fundamentals ($29.59B revenue, $2.68 EPS, 54% margins) but leaves no margin for error given a confirmed death cross with widening 50/200 SMA gap ($8.65 and expanding), receivables +96% YoY vs revenue +85% YoY indicating DSO extension and working capital deterioration, and a 97% no-cut Fed pricing environment that makes the 1.46 beta a structural headwind. Hold residual with a $337 hard stop; re-engage on $366.50 close (200 SMA reclaim) with volume >18M or tactical reload on $338-340 flush with stabilization.

Outcome

✓

Return

+1.58%

Status

scored

Approve a measured Overweight on NVDA with Tier 1 reduced to 25-30% of target (~0.5-0.7% NAV) at $345-355, conditional on either 10 EMA reclaim at $353.78 with volume >15M or a flush to $322-337 with stabilization—explicitly rejecting the trader's proposed 35% which replicates the failed 09-25 Overweight at the same level. Tier 2 (35% of target) gated on $375 close with volume >18M and RSI>50, Tier 3 (35-40% of target) only on $400 breakout with 200 SMA reclaim and volume >25M. Hard stop at $322, soft stop at $308, alpha circuit breaker at -0.75% vs SPY over 15 days, time invalidation mid-October if 200 SMA not reclaimed.

Outcome

–

Return

-0.92%

Status

scored

Initiate measured Overweight on AVGO with a three-tranche entry architecture (35-45% at $352-355, 20-25% on reversal at $338-340 with RSI divergence, 15-20% on breakout above $367 with expanding volume) and hard stop at $337.80. The rating honors the fundamental asymmetry (PEG 0.35, $30.6B FCF, 54% operating margins) while using the broken MA stack, distribution volume, and unresolved forward EPS arithmetic ($2.68 × 4 = $10.72, not $19.38) as risk-overlay gates for tier escalation.

Outcome

✓

Return

+0.70%

Status

scored

Maintain AVGO at HOLD with a tiered architecture: deploy Tier 1 (0.5% NAV) immediately at the $350-$355 asymmetry, gate Tier 2 (0.7% NAV) and Tier 3 (0.9% NAV) on structural confirmations ($367-$376 breakout with volume >18M and RSI>50; $400 breakout with volume >25M respectively). Hard stop at $325 close, trim into $367-$376 resistance, and use -0.75% alpha circuit breaker vs SPY over 15 days as primary exit discipline.

Outcome

✓

Return

-1.30%

Status

scored

Maintain AVGO at Hold with a redesigned tiered architecture that deploys the 0.5% NAV tier 1 starter immediately at the $355 asymmetry zone rather than waiting for 200 SMA confirmation that may never materialize, directly applying the 09-22 binding reflection lesson; total position capped at ~2.1% NAV across three tiers with hard stop at $338.76 and pre-committed 25% trims into Q4 FY26 earnings and December FOMC.

Outcome

✗

Return

-2.62%

Status

scored

Maintain AVGO at Hold as the correct consensus call given the fundamental case (PEG 0.36, 18.8x forward P/E, 147% EPS growth, 42% FCF margins) and broken-tape structure that does not yet warrant full Overweight. The architecture is redesigned to avoid the 09-21 failure mode: relaxed volume threshold (>18M instead of >22M), widened trim band ($356.48 10 EMA), pre-committed 20% calendar trim into Q4 FY26 earnings, and mid-October time-based invalidation if 200 SMA not reclaimed. Hard stop $338 with -0.75% relative SPY circuit breaker over 15 days.

Outcome

✓

Return

+0.52%

Status

scored

Maintain AVGO at neutral exposure (HOLD rating) with staged entry triggers at $379, $389, and $400 rather than aggressive adds, while defending a hard stop at $338 and taking partial profits at $400. The ~10% upside vs ~7% downside risk/reward from current levels ($362) is not asymmetric enough for full directional commitment, and the forward EPS estimate of $19.38 won't be validated until Q4 FY26 earnings in mid-December 2026.

Outcome

✓

Return

+1.41%

Status

scored

Maintain AVGO at 8-10% portfolio weight with active architecture, as the aggressive analyst's PEG 0.34 thesis contains a fatal arithmetic error (Q3 $2.68 × 4 = $10.72, not $19.38), and technical structure remains unconfirmed below 200-SMA ($368.39) with intact death cross. Allow modest starter adds at $337-345 with strict $332 stop, and pre-commit automatic 20% reduction into Q4 FY26 earnings and hyperscaler capex catalysts.

Outcome

✓

Return

+2.97%

Status

scored

Upgraded from Hold to Overweight with a calibrated 25% starter tranche (reduced from trader's proposed 50%) in the $343-348 zone, requiring modest confirmation before full deployment. The 09-16 Hold delivered +1.2% alpha with active architecture, validating escalation to Overweight while respecting the binding 09-15 lesson that confirmation gates prevent the bleeding-Hold pattern. Hard stop at $315 (close) with collar hedge and pre-committed FOMC reduction limits risk while capturing the asymmetric fundamental setup (PEG 0.34, 50%+ growth at 17.9x forward P/E).

Outcome

✗

Return

+2.29%

Status

scored

Maintain AVGO at Hold with an active architecture targeting the ~6% cumulative alpha drag from four prior passive Holds; trim 20–30% into rallies at $360–$370 and stage 10–15% adds on confirmed technicals (daily close above $353.85 with volume first, weekly close above $368.78 with death cross averted second), with a -0.75% SPY-relative alpha circuit breaker over 15 days, pre-committed 20% reduction ahead of FOMC, and a $340–$300 put spread hedge at 2–3% of notional. The fundamental profile is structurally elite (17.5x P/E, 216% YoY net income growth, $30.6B FCF, 44% ROE) but the technical structure is broken (death cross approaching, MACD at -10.64, lower highs since August) and the hostile macro regime (Polymarket 95% no-cut, 10Y pressing 5%) warrants disciplined position sizing (8–10% benchmark, max 1.5x for existing holders) rather than aggressive accumulation without confirmation gates.

Outcome

✓

Return

+0.07%

Status

scored

Upgrade AVGO to Overweight with a measured 25% initial tranche (~2% of portfolio) at $339, rejecting both the aggressive 40% starter and conservative full deferral. The collar hedge (buy $320 puts, sell $380-400 calls at 1-2% net cost) corrects the underpriced put estimate while providing asymmetric downside protection; a -0.75% relative-to-SPY alpha circuit breaker and hard stop at $315 encode the prior decision stack's binding lessons against the documented bleeding-Hold failure mode on this name.

Outcome

✓

Return

-1.58%

Status

scored

Maintain AVGO at 8-10% portfolio weight with an active Hold architecture to address the -0.5%, -0.4%, and -4.3% alpha drag from prior passive Hold calls. For sidelined capital, deploy a small starter position (1/3 intended size) at $344 with a strict $320 stop, adding only on two of three confirmation gates (RSI<30, lower-band reclaim, or close >$350 on volume). Pre-commit an automatic 20% position reduction into the FOMC meeting, hedge with $340-$300 put spreads at 2-3% notional, and employ a tighter -1% relative-to-SPY alpha circuit breaker rather than the previous -2% threshold.

Outcome

✗

Return

-4.77%

Status

scored

Maintain AVGO at Hold with an active rather than passive architecture; adopt a tighter -1% relative circuit breaker, pre-commit a 25% gross reduction into the FOMC, and structure a $340-$300 put spread at 2-3% of position notional as cost-efficient tail protection. Position sizing at 8-10% of portfolio with a $342 close-basis invalidation and $383 volume-confirmed scale-in trigger.

Outcome

✓

Return

+0.32%

Status

scored

Maintain AVGO at Hold with 8-10% portfolio weight and a tail hedge (long puts $340-350 strike, 6-9 month tenor, 3-5% of position notional), replacing the trader's operationally broken $340/$339 stop with either a weekly close below $340 on expanding volume or an ATR-calibrated hard stop at $325-330; bullish re-engagement requires $383 reclaim on volume plus one of three confirmation gates (RSI>50, MACD bullish cross, defended VWMA on volume).

Outcome

✓

Return

-0.97%

Status

scored

Adopt a tactical Underweight rating on AVGO with a 25–30% trim of existing exposure into the $368–$378 zone while avoiding fresh long initiation at $364; employ a two-step stop-loss architecture (weekly close below $365 trims another 25%, below 200 SMA at $369 on volume trims to half) with defined reload triggers at $383.50 (re-rating) or $337 (bearish capitulation), and tail-hedge via $340–$350 puts at 6–9 month tenor covering 5–7% of notional.

Outcome

–

Return

-1.13%

Status

scored

Upgraded from Hold to Overweight with a staged accumulation framework, initiating a starter tranche at 30-40% of intended position at current levels. Entry is protected by a volatility-calibrated stop at $345 (2x ATR, ~6% realized gap risk), with a confirmation add planned on a daily close above $375 supported by above-average volume, RSI > 50, and MACD bullish crossover. Price target is $475 with tier profit-taking at $400-410, $475, and $500+.

Outcome

✓

Return

+2.98%

Status

scored

Initiate AVGO with BUY rating on decisive fundamental conviction — 18.5x forward P/E, PEG 0.42 against 48% revenue growth, 67.9% operating margins, and Hock Tan's explicit guidance for revenue doubling in 2027 and 2028. Execute via disciplined three-tranche scale-in (35%/30%/35%) with tight stop at $345, hedging tail risk via $340-350 puts at 5-7% notional for 6-9 month tenor.

Outcome

✓

Return

+0.21%

Status

scored

Initiate AVGO at Overweight with 35-45% target weight at $357, using a $328 hard stop and catalyst-responsive staging (10-15% adds on soft payrolls, 15-20% adds on dovish FOMC), while hedging with 5-7% notional in long puts at $340-350 strike. The Overweight rating reflects fundamental conviction (PEG 0.42, 48% revenue growth, $27B FCF) that is too strong for Hold, tempered by technical caution (MACD -8.49, RSI 37.5, 200 SMA violated) that prevents a one-shot Buy positioning.

Outcome

✗

Return

-2.74%

Status

scored

Maintain core AVGO exposure at ~$367 with a defensive posture and cheap tail-hedge through the 2-4 week technical resolution window; do not add capital until $368.86 is reclaimed on volume with follow-through, but do not exit given the elite fundamental floor (PEG 0.42, $27.2B TTM FCF, AI revenue tripled YoY). Trim modestly to neutral weight if currently overweight (bias to upper end of 10-15% range), and carry OTM puts at $340-350 strike, 6-9 month tenor to insure against the path to $333.84 lower Bollinger, with hard invalidation at $355.59 daily close on expanding volume; 12-month $450 target unchanged.

Outcome

✓

Return

-0.66%

Status

scored

Maintain AVGO at or below benchmark weight (~1.25–1.5% NAV cap) through the September 2 Q3 FY26 binary catalyst, with a 10–15% trim if currently >200bps overweight; post-earnings re-engagement protocols are gated on three gates (revenue beat ≥3%, Q4 AI guide ≥$18B, no AR/revenue deterioration) with beat-and-raise above $386 triggering 25–50% add-back and close below $335 triggering downgrade to Underweight.

Outcome

✓

Return

-0.18%

Status

scored

Maintain core AVGO exposure at ~$371 with a refined hedge architecture through the September 2 Q3 FY26 earnings print. For existing longs, trim 10–15% into pre-earnings rallies toward $379 or $386, overlay covered calls at higher strikes ($415–$425) or half-notional at $390–$400, and add long puts at $340–$350 as tail hedges, with hard stop at $354 on daily close basis. Do not initiate fresh capital positions ahead of the print; re-engage only after confirmed beat-and-raise with $386 reclaim on volume and MACD contraction within 3–5 sessions.

Outcome

✓

Return

+0.42%

Status

scored

Maintain AVGO at or below benchmark weight (1.25-1.5% NAV) ahead of the Sept 2 Q3 FY26 print, with a stop at $354 and put-spread hedge ($345/$355 strikes) re-priced closer to spot to capture the most-likely downside touchpoint; do not add capital pre-binary given the 200 SMA defense (less than 2% of ATR), widening MACD histogram (-2.5 → -2.8 → -3.43), and failed RSI bounce (43.90 → 42.75). Reassess post-print using the pre-committed decision tree: upgrade to Overweight on beat-and-raise with close above $386 on expanding volume targeting $420-428; hold in-line print in $360-380 range; downgrade to Underweight and trim to ~0.75% NAV on close below $354 targeting $338-340 lower Bollinger.

Outcome

✓

Return

-0.74%

Status

scored

Maintain AVGO at Hold with the existing put-spread hedge ($355/$335 longs at 5-7% notional) through the September 2 print; no aggressive adds at the 200 SMA, which is a diagnostic, not an entry trigger. For positions >200bps overweight versus benchmark with price below the 50 SMA at $386, execute a 10-15% trim to neutralize binary event risk; if at or under benchmark weight, hold full size and let the put spread carry the downside insurance. Re-engagement triggers: beat-and-raise plus $386 reclaim on volume adds 25-50% back; disappointment triggers reassessment at the $340 lower Bollinger.

Outcome

✓

Return

+4.49%

Status

scored

Accumulate AVGO gradually to ~1.25% NAV cap with a staged approach: deploy 25–30% of intended size at $350–$360 before Nvidia's earnings and the Sep-2 Q3 FY26 print, defer subsequent tranches until after both catalysts clear, and add on confirmed closes above $368.35 and $386.66. Use a $339–$342 stop and protective puts or a collar on the initial tranche to define downside through the highest-event-risk week; trim only if price closes below $342.10 on expanding volume or forward EPS revisions exceed 15%.

Outcome

✓

Return

-0.32%

Status

scored

Maintain AVGO at $356.74 with a 5–7% notional hedge (Sept $340/$355 put spreads) through the Sep 2 Q3 FY26 earnings, given the symmetric $12 risk/reward setup versus technical breakdown and binary catalyst 8 days out. Upgrade to Overweight on move above 200 SMA with positive MACD cross; downgrade to Underweight on break below $340.

Outcome

✓

Return

-0.56%

Status

scored

Trim 30-45% of AVGO exposure across two tranches to capture asymmetric downside while deploying 5-7% of remaining notional in September $340/$355 put spreads for beta-neutral hedging; structural stop set at the lower Bollinger Band ($348.65) rather than the trader's fixed $340 stop to avoid premature liquidation. The Underweight rating is supported by a breached 200-SMA on expanding volume, MACD histogram at -6.22, and RSI at 35.4, with a $340 price target over a 3-4 week catalyst window tied to NVDA (Aug 26) and Marvell (Aug 27) earnings, subject to reassessment pending credit spread stabilization and weekly close above 200-SMA.

Outcome

✓

Return

-2.63%

Status

scored

Maintain AVGO core position at $368 with a 5-7% notional put hedge (Sept $340-350 strikes); hard stop at $352 (lower Bollinger band), trim triggers on two consecutive closes below $365 with rising volume (reduce 25-33%); re-engagement only on capitulation flush ($340-350, RSI<30, 40M+ volume) or confirmed close above $385 with MACD bullish cross. The 08-18 and 08-17 binding reflections mandate proper hedge sizing and pre-committed trim triggers to neutralize the 1.47 beta without repeating the -4.8% alpha failure mode.

Outcome

–

Return

+1.21%

Status

scored

Trim 20-25% of AVGO via a two-tranche execution (tranche one at market ~10-12% near $362-364; tranche two ~10-12% as scaled sell into $380-388 with acceleration if lower Bollinger at $354.77 breaks on expanding volume), while hedging the residual 75-80% position with September $340/$355 put spreads at 5-7% of remaining notional. A structural stop sits at $396-400 (1.5 ATR above the $388 breakdown resistance), and the position will be re-evaluated on Q3 FY26 earnings (~September 2, 2026): upgraded to Hold on a clean beat with inventory normalization, or downgraded to Sell on a 5%+ miss with continued working-capital deterioration.

Outcome

✗

Return

+0.43%

Status

scored

Downgrade AVGO to Underweight and trim 30-35% of the position immediately, redeploying into broader semiconductor diversification (NVDA, AMD, MRVL). Execute properly sized put spreads ($355/$340) at 5-7% of notional on the remaining 65-70% position, with a hard stop at $295 and soft stop at $329 (2x ATR). Re-engage on confirmation of close above $368 with >20M volume or high-volume washout to $330-340 with RSI divergence, sized at half-normal.

Outcome

✗

Return

-4.61%

Status

scored

Hold AVGO through Q3 FY26 earnings (Sep 2) with existing exposure maintained and September $355/$365 put spreads already executed as a binding hedge; the rating preserves structural upside (47.9% revenue growth, $32.8B FCF, PEG 0.44) while protecting against asymmetric downside risk from macro headwinds (30-year yields at 19-year highs) into the binary catalyst, with a conditioned one-third add planned post-beat only if 200-SMA reclaims $368 and yields remain stable.

Outcome

✗

Return

-3.17%

Status

scored

Maintain AVGO at $392 with EXECUTED protective puts at $380-385 strike, Sept/Oct expiry (before Q3 FY26 earnings ~Sept 2), sized at less than 3% of position value—converting binary tail risk into a defined cost. Hard stop on equity at $388.50 (50 SMA breach); soft stop $385 intraday. Trim 25-30% into any relief rally to the $400-410 zone; do NOT initiate fresh longs. Re-engagement only on confirmed close above $415 on greater than 20M volume, or high-volume washout to $363-368 (200 SMA confluence) at half-normal sizing with stop at $358.

Outcome

✓

Return

-0.14%

Status

scored

Maintain AVGO at $393 with protective puts at $380-385 strike (Sept/Oct expiry) sized at under 3% of position value, converting the binary Q3 FY26 catalyst risk into a defined cost. Hard equity stop at $388.50 (50 SMA breach) with soft intraday stop at $385; trim 25-30% into any relief rally to $400-410. Do not initiate fresh longs—re-engagement only on confirmed close above $415 on above-20M volume or high-volume washout to $363-368 at half sizing.

Outcome

✗

Return

-5.94%

Status

scored

Maintain AVGO at $417 with HOLD rating and three explicit execution steps: avoid adding above $410 due to MACD divergence and $126B goodwill risk, buy $400 strike protective puts at <3% of position value pre-earnings to convert binary tail risk into a defined cost, and set hard stop at $355 with conditional half-size add trigger at $398-405 contingent on 50-SMA and RSI stabilization. Post-print positioning varies by outcome—add on selloff for beat-and-raise, prepare for 5-10% drawdown on in-line results, or trim 25-33% on miss/soft guide.

Outcome

✓

Return

+0.43%

Status

scored

Maintain AVGO at $416 with $390 hard stop and $400 strike protective puts at <3% of position value to neutralize gap risk in this 1.47-beta name ahead of the September 2 binary catalyst. Execute tiered scale-ins at $400-405 (capped 20-25% of position) and on Polymarket $17B AI revenue strike exceeding 50%, while reframing post-earnings re-entry based on beat magnitude rather than relying on fragile stop levels.

Outcome

–

Return

-0.01%

Status

scored

Trim AVGO 15-20% immediately at $416 given confirmed MACD exhaustion and bearish engulfing on elevated 1.47 beta into a CPI/NVDA catalyst window; deploy ~30% of trim proceeds into 3-6 month $400 puts for defined-cost tail protection, keeping remaining ~70% in cash with hard stop at $380.

Outcome

✗

Return

-1.50%

Status

scored

Deploy 1–1.5% of portfolio as a tactical starter at $422 with a hard stop at $390, building toward a 5–7% target weight through a four-tranche layered framework with add triggers at $429.74 (confirmed breakout), $408/$395 (pullback to 10 EMA/50 SMA), and $390 (deep value flush). The 0.48 PEG, 48.9% operating margins, and $10.26B quarterly FCF provide the structural foundation, while the 15–20% starter sizing respects the unconfirmed breakout and volume contraction of 53% from the 8/04 breakout day.

Outcome

✓

Return

-1.25%

Status

scored

Maintain AVGO at $427 with a 25-30% trim into the $440-460 rally zone ahead of CPI and Q2 FY26 earnings, while setting a structurally valid hard stop below $380 (not at the $395 entry price) to properly account for downside risk given the 700bp sequential margin compression and 201% receivables growth against 48% revenue growth.

Outcome

✓

Return

+1.71%

Status

scored

Initiate a phased build to 3-5% overweight with a 1-1.5% starter at $420 (not 50% of target), scaling to 2.5-3% on pullback to $400-405 and full 3-5% on flush to $385-395; trim 15% pre-earnings. The Overweight rating balances strong fundamentals (47.9% YoY revenue growth, 0.44 PEG, $27B+ FCF) against technical extension (7.4% above VWMA, non-confirmed breakout) and binary event risk, while avoiding the alpha-donor failure modes of prior pure Hold and aggressive full-position entries.